2.0(top 20%)
impact factor
2.8K(top 10%)
papers
28.4K(top 10%)
citations
62(top 10%)
h-index
2.7(top 20%)
impact factor
4.8K
all documents
30.6K
doc citations
89(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki‐67Hematological Oncology1984302
2Managing the toxicities of CAR T‐cell therapyHematological Oncology2019214
3Clinical and prognostic relevance of the Kiel classification of non‐Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study GroupHematological Oncology1984198
4Criteria for the cytologic subclassification of follicular lymphomas: A Proposed alternative methodHematological Oncology1983185
5PRESENCE OF EPSTEIN-BARR VIRUS DNA IN NASAL LYMPHOMAS OF B AND ‘T’ CELL TYPEHematological Oncology1990177
6Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosisHematological Oncology1989172
7Multiple myeloma: Every year a new standard?Hematological Oncology2019155
8Prognostic impact of tumour‐infiltrating Th2 and regulatory T cells in classical Hodgkin lymphomaHematological Oncology2009153
9Angiotropic large cell lymphoma (ALCL): Morphological, immunohistochemical and genotypic studies with analysis of previous reportsHematological Oncology1989147
10Pathophysiology of acute graft-versus-host diseaseHematological Oncology2003145
11Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesisHematological Oncology2005136
12Extranodal NK/T‐cell lymphoma: diagnosis and treatment cuesHematological Oncology2008135
13Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapyHematological Oncology2007134
14Intravascular lymphoma: a neoplasm of ‘homeless’ lymphocytes?Hematological Oncology2006132
15The dog as a possible animal model for human non‐Hodgkin lymphoma: a reviewHematological Oncology2013132
16CAR T‐cell therapy: Full speed aheadHematological Oncology2019131
17Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factorsHematological Oncology2004129
18Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entityHematological Oncology2009127
19Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trialHematological Oncology2009125
20Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?Hematological Oncology1989119
21Hepatitis B infection in patients with lymphomasHematological Oncology1990119
22Natural killer cell lymphoma/leukemia: pathology and treatmentHematological Oncology1997119
23Modifications in the classification of primary myelodysplastic syndromes: The addition of a scoring systemHematological Oncology1985114
24The new World Health Organization classification of lymphomas: the past, the present and the futureHematological Oncology2001111
25Richter syndrome: molecular insights and clinical perspectivesHematological Oncology2009109
26Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literatureHematological Oncology201198
27Hypermethylation of gene promoters in hematological neoplasiaHematological Oncology200297
28Rituximab monotherapy is highly effective in splenic marginal zone lymphomaHematological Oncology200796
29Update on the molecular biology of mantle cell lymphomaHematological Oncology200689
30Genetic and phenotypic analysis of B‐cell post‐transplant lymphoproliferative disorders provides insights into disease biologyHematological Oncology200889
31The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluidHematological Oncology201886
32Epidemiology Of Hodgkin's disease: a reviewHematological Oncology200484
33Secondary central nervous system involvement by non-Hodgkin's lymphoma: The risk factorsHematological Oncology200682
34High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphomaHematological Oncology201582
35ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R2‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphomaHematological Oncology201982
36Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptakeHematological Oncology200681
37When epigenetics kills: MLL fusion proteins in leukemiaHematological Oncology200580
38Serum albumin level at diagnosis of diffuse large B‐cell lymphoma: an important simple prognostic factorHematological Oncology201680
39Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosisHematological Oncology199379
40Fertility preservation after chemotherapy for Hodgkin lymphomaHematological Oncology201079
41Potential role for low dose limited-field radiation therapy (2 × 2 grays) in advanced low-grade non-Hodgkin's lymphomasHematological Oncology199478
42Role of Bcl-2 family of proteins in malignancyHematological Oncology200278
43Treatment of early chronic lymphocytic leukemia: Intermittent chlorambucil versus observationHematological Oncology198877
44The 2016 updated WHO classification of lymphoid neoplasiasHematological Oncology201775
45A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory b cell malignanciesHematological Oncology198974
46Evidence for the detection of the normal counterpart of hodgkin and sternberg‐reed cellsHematological Oncology198374
47Radiation therapy for localized low-grade non-Hodgkin's lymphomasHematological Oncology200573
48Prognostic factors for primary gastrointestinal lymphomaHematological Oncology199572
49ABCG2 (BCRP) expression in normal and malignant hematopoietic cellsHematological Oncology200372
50The root of many evils: indolent large granular lymphocyte leukaemia and associated disordersHematological Oncology201071